NORTH CHICAGO, Ill. , Sept. 17, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its third-quarter 2018 financial results on Friday, November 2 2018 , before the market opens. AbbVie will host a live webcast of the earnings conference call

NORTH CHICAGO, Ill. , Sept. 7, 2018 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.96 per share. The cash dividend is payable Nov. 15, 2018 to stockholders of record at the close of business on Oct. 15, 2018 .

NORTH CHICAGO, Ill. , Aug. 28, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Morgan Stanley 16 th  Annual Global Healthcare Conference on Wednesday, September 12, 2018. Bill Chase , executive vice president and chief financial

- Reports Second-Quarter Diluted EPS of $1.26 on a GAAP Basis; Adjusted Diluted EPS of $2.00 Reflects Growth of 40.8 Percent - Delivers Second-Quarter Net Revenues of $8.278 Billion on a GAAP Basis; Adjusted Net Revenues of $8.258 Billion Increased 17.1 Percent on an Operational Basis -

NORTH CHICAGO, Ill. , July 10, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its second-quarter 2018 financial results on Friday, July 27, 2018 , before the market opens. AbbVie will host a live webcast of the earnings conference call at

NORTH CHICAGO, Ill. , June 14, 2018 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.96 per share.  The cash dividend is payable Aug. 15, 2018 to stockholders of record at the close of business on July 13, 2018 .

NORTH CHICAGO, Ill. , June 4, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV) today announced the final results of its modified Dutch auction tender offer, which expired at 12:00 midnight, New York City time, at the end of May 29, 2018 . AbbVie has accepted for purchase 72,815,534 shares of its common

NORTH CHICAGO, Ill. , May 30, 2018 /PRNewswire/ --  AbbVie (NYSE: ABBV) today announced the preliminary results of its modified Dutch auction tender offer, which expired at 12:00 midnight, New York City time, at the end of May 29, 2018 . This update replaces the preliminary results announced at

NORTH CHICAGO, Ill. , May 30, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the preliminary results of its modified Dutch auction tender offer, which expired at 12:00 midnight, New York City time, at the end of May 29, 2018 . Based on the preliminary count by Computershare Trust Company,

NORTH CHICAGO, Ill. , May 29, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Goldman Sachs 39 th Annual Global Healthcare Conference on Tuesday, June 12, 2018 . Richard A. Gonzalez , chairman and chief executive officer, will